MedTrace Logo

A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Nasopharyngeal Carcinoma.

NCT05682703 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2023-01-12

No results posted yet for this study

Summary

The transformation process of nasopharyngeal carcinoma is complex, so it is particularly important to explore the relationship between various disease states on its clinical pathway. Therefore, we carried out this study to explore the changes of plasma and urine metabolites at different stages during the occurrence and development of nasopharyngeal carcinoma.

Conditions

  • Nasopharyngeal Carcinoma
  • EBV Infection

Interventions

DIAGNOSTIC_TEST

Proteomics technology and liquid biopsy

using proteomics technology and liquid biopsy to investigate the changes of plasma and urine metabolites by collecting residual blood and urine from routine diagnosis and treatment or physical examination

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Principal Investigators

  • jian guan, MD · Nanfang Hospital, Southern Medical University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-23
Primary Completion
2025-11-20
Completion
2025-12-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05682703 on ClinicalTrials.gov